Show simple item record

Desistance, Self‐treatment, or Substitution: Decisions about Cannabis Use During Pregnancy

dc.contributor.authorGreyson, Devon
dc.contributor.authorRoosevelt, Lee
dc.contributor.authorBoyd, Carol J.
dc.date.accessioned2021-03-02T21:45:30Z
dc.date.available2022-02-02 16:45:29en
dc.date.available2021-03-02T21:45:30Z
dc.date.issued2021-01
dc.identifier.citationGreyson, Devon; Roosevelt, Lee; Boyd, Carol J. (2021). "Desistance, Self‐treatment, or Substitution: Decisions about Cannabis Use During Pregnancy." Journal of Midwifery & Women’s Health 66(1): 96-100.
dc.identifier.issn1526-9523
dc.identifier.issn1542-2011
dc.identifier.urihttps://hdl.handle.net/2027.42/166398
dc.description.abstractCannabis is the most commonly used drug during pregnancy in the United States and Canada, and the American College of Obstetricians and Gynecologists recommends that all pregnant individuals be screened for cannabis use and counseled regarding potential adverse health impacts of use. However, those considering or using cannabis during pregnancy report experiencing stigma and lack of information from health care providers and, thus, frequently rely on friends, family, and the internet for information. This article describes 3 types of decisions individuals may be making about cannabis use during pregnancy and suggests approaches health care providers may take to minimize judgment and provide optimal support for informed cannabis use decisions among pregnant individuals. Desistance decisions involve consideration of whether and how to reduce or stop using during pregnancy. Self‐treatment decisions are made by those exploring cannabis to help alleviate troublesome symptoms such as nausea or anxiety. Substitution decisions entail weighing whether to use cannabis instead of another substance with greater perceived harms. Health care providers should be able to recognize the various types of cannabis use decisions that are being made in pregnancy and be ready to have a supportive conversation to provide current and evidence‐based information to individuals making desistance, self‐treatment, and substitution decisions. Individuals making desistance decisions may require support with potential adverse consequences such as withdrawal or return of symptoms for which cannabis was being used, as well as potentially navigating social situations during which cannabis use is expected. Those making self‐treatment decisions should be helped to fully explore treatment options for their symptoms, including evidence on risks and benefits. Regarding substitution decisions, health care providers should endeavor to help pregnant individuals understand the available evidence regarding risks and benefits of available options and be open to revisiting the topic over time.
dc.publisherWiley Periodicals, Inc.
dc.subject.othermarijuana use
dc.subject.othercounseling
dc.subject.otherdecision‐making
dc.subject.otherpregnancy
dc.subject.othercannabis
dc.titleDesistance, Self‐treatment, or Substitution: Decisions about Cannabis Use During Pregnancy
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelNursing
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/166398/1/jmwh13205_am.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/166398/2/jmwh13205.pdf
dc.identifier.doi10.1111/jmwh.13205
dc.identifier.sourceJournal of Midwifery & Women’s Health
dc.identifier.citedreferenceMcCabe SE, Wilens TE, Boyd CJ, Chua K‐P, Voepel‐Lewis T, Schepis TS. Age‐specific risk of substance use disorders associated with controlled medication use and misuse subtypes in the United States. Addict Behav. 2019; 90: 285 ‐ 293.
dc.identifier.citedreferenceVolkow ND, Han B, Compton WM, McCance‐Katz EF. Self‐reported medical and nonmedical cannabis use among pregnant women in the United States. JAMA. 2019; 322 ( 2 ): 167 ‐ 169.
dc.identifier.citedreferenceBraillon A, Bewley S. Committee opinion no. 722: marijuana use during pregnancy and lactation. Obstet Gynecol. 2018; 131 ( 1 ): 164.
dc.identifier.citedreferenceHolland CL, Rubio D, Rodriguez KL, et al. Obstetric health care providers’ counseling responses to pregnant patient disclosures of marijuana use. Obstet Gynecol. 2016; 127 ( 4 ): 681 ‐ 687.
dc.identifier.citedreferenceGreyson D. Unmet information needs regarding cannabis decisions in pregnancy. Proc Assoc Infor Sci Technol. 2020; 57 ( 1 ): e335.
dc.identifier.citedreferenceChang JC, Tarr JA, Holland CL, et al. Beliefs and attitudes regarding prenatal marijuana use: perspectives of pregnant women who report use. Drug Alcohol Depend. 2019; 196: 14 ‐ 20.
dc.identifier.citedreferenceBarbosa‐Leiker C, Burduli E, Smith CL, Brooks O, Orr M, Gartstein M. Daily cannabis use during pregnancy and postpartum in a state with legalized recreational cannabis. J Addic Med. 2020; 14 ( 6 ): 467 ‐ 474.
dc.identifier.citedreferenceWhat you need to know about marijuana use and pregnancy. Centers for Disease Control and Prevention. 2018. Accessed January 25, 2020. https://www.cdc.gov/marijuana/factsheets/pregnancy.htm
dc.identifier.citedreferenceKo JY, Farr SL, Tong VT, Creanga AA, Callaghan WM. Prevalence and patterns of marijuana use among pregnant and nonpregnant women of reproductive age. Am J Obstet Gynecol. 2015; 213 ( 2 ): 201.e1 ‐ 201.e10.
dc.identifier.citedreferenceYoung‐Wolff KC, Sarovar V, Tucker LY, et al. Association of nausea and vomiting in pregnancy with prenatal marijuana use. JAMA Intern Med. 2018; 178 ( 10 ): 1423 ‐ 1424.
dc.identifier.citedreferenceRoberson EK, Patrick WK, Hurwitz EL. Marijuana use and maternal experiences of severe nausea during pregnancy in Hawai’i. Hawaii J Med Public Health. 2014; 73 ( 9 ): 283 ‐ 287.
dc.identifier.citedreferenceTakakuwa KM, Schears RM. Why pregnant women may justifiably choose to use cannabis. JAMA Intern Med. 2019; 179 ( 1 ): 120.
dc.identifier.citedreferenceShorten A, Shorten B, Kennedy HP. Complexities of choice after prior cesarean: a narrative analysis. Birth. 2014; 41 ( 2 ): 178 ‐ 184.
dc.identifier.citedreferenceBoyd CJ, McCabe SE. Coming to terms with the nonmedical use of prescription medications. Subst Abuse Treat Prev Policy. 2008; 3: 22.
dc.identifier.citedreferenceMcCabe SE, Boyd CJ. Do motives matter? Nonmedical use of prescription medications among adolescents. Prev Res. 2012; 19 ( 1 ): 10 ‐ 13.
dc.identifier.citedreferenceBoyd CJ, West B, McCabe SE. Does misuse lead to a disorder? The misuse of prescription tranquilizer and sedative medications and subsequent substance use disorders in a U.S. longitudinal sample. Addict Behav. 2018; 79: 17 ‐ 23.
dc.identifier.citedreferenceMcCabe SE, West BT, Veliz P, McCabe VV, Stoddard SA, Boyd CJ. Trends in medical and nonmedical use of prescription opioids among US adolescents: 1976‐2015. Pediatrics. 2017; 139 ( 4 ): e20162387.
dc.identifier.citedreferenceMcCabe SE, Veliz P, Boyd CJ, Schulenberg JE. Medical and nonmedical use of prescription sedatives and anxiolytics: adolescents’ use and substance use disorder symptoms in adulthood. Addict Behav. 2017; 65: 296 ‐ 301.
dc.identifier.citedreferenceYoung A, McCabe SE, Cranford JA, Ross‐Durow P, Boyd CJ. Nonmedical use of prescription opioids among adolescents: subtypes based on motivation for use. J Addict Dis. 2012; 31 ( 4 ): 332 ‐ 341.
dc.identifier.citedreferenceMcCabe SE, Boyd CJ, Teter CJ. Subtypes of nonmedical prescription drug misuse. Drug Alcohol Depend. 2009; 102 ( 1 ): 63 ‐ 70.
dc.identifier.citedreferenceVoon P, Kerr T. “Nonmedical” prescription opioid use in North America: a call for priority action. Subst Abuse Treat Prev Policy. 2013; 8: 39.
dc.identifier.citedreferenceJarlenski M, Tarr JA, Holland CL, Farrell D, Chang JC. Pregnant women’s access to information about perinatal marijuana use: a qualitative study. Womens Health Issues. 2016; 26 ( 4 ): 452 ‐ 459.
dc.identifier.citedreferenceBrown QL, Sarvet AL, Shmulewitz D, Martins SS, Wall MM, Hasin DS. Trends in marijuana use among pregnant and nonpregnant reproductive‐aged women, 2002‐2014. JAMA. 2017; 317 ( 2 ): 207 ‐ 209.
dc.identifier.citedreferenceYoung‐Wolff KC, Tucker LY, Alexeeff S, et al. Trends in self‐reported and biochemically tested marijuana use among pregnant females in California from 2009‐2016. JAMA. 2017; 318 ( 24 ): 2490 ‐ 2491.
dc.identifier.citedreferenceMetz TD, Silver RM, McMillin GA, et al. Prenatal marijuana use by self‐report and umbilical cord sampling in a state with marijuana legalization. Obstet Gynecol. 2019; 133 ( 1 ): 98.
dc.identifier.citedreferenceHoward DS, Dhanraj D, Devaiah G, Lambers D. Marijuana use in pregnancy and its effects on birth weight and gestational age at delivery [17R]. Obstet Gynecol. 2017; 129 ( 5 ): 187S.
dc.identifier.citedreferenceBayrampour H, Zahradnik M, Lisonkova S, Janssen P. Women’s perspectives about cannabis use during pregnancy and the postpartum period: an integrative review. Prev Med. 2019; 119: 17 ‐ 23.
dc.identifier.citedreferenceMark K, Terplan M. Cannabis and pregnancy: maternal child health implications during a period of drug policy liberalization. Prev Med. 2017; 104: 46 ‐ 49.
dc.working.doiNOen
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.